Fujita S - Search Results

1

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non-Hodgkin's lymphoma.

Hamada M, Yakushijin Y, Ohtsuka M, Kakimoto M, Yasukawa M, Fujita S. Hamada M, et al. Among authors: fujita s. Br J Haematol. 2003 May;121(3):439-47. doi: 10.1046/j.1365-2141.2003.04311.x. Br J Haematol. 2003. PMID: 12716366 Free article.

2

[Double B-cell malignancies with simultaneous onset].

Yakushijin Y, Sakai I, Takada K, Yasukawa M, Fujita S. Yakushijin Y, et al. Among authors: fujita s. Rinsho Ketsueki. 2004 Mar;45(3):218-22. Rinsho Ketsueki. 2004. PMID: 15103935 Review. Japanese.

3

Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.

Niiya H, Sakai I, Lei J, Azuma T, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M. Niiya H, et al. Among authors: fujita s. Exp Hematol. 2005 Jul;33(7):811-8. doi: 10.1016/j.exphem.2005.04.004. Exp Hematol. 2005. PMID: 15963857 Free article.

4

Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes.

Azuma T, Makita M, Ninomiya K, Fujita S, Harada M, Yasukawa M. Azuma T, et al. Among authors: fujita s. Br J Haematol. 2002 Mar;116(3):601-3. doi: 10.1046/j.0007-1048.2001.03329.x. Br J Haematol. 2002. PMID: 11849218 Free article.

5

[Granulocytic sarcoma developing in lymph nodes].

Watanabe I, Yakushijin Y, Sakai I, Yasukawa M, Fujita S. Watanabe I, et al. Among authors: fujita s. Rinsho Ketsueki. 2002 May;43(5):378-83. Rinsho Ketsueki. 2002. PMID: 12096491 Japanese.

6

Antilung cancer effect of WT1-specific cytotoxic T lymphocytes.

Makita M, Hiraki A, Azuma T, Tsuboi A, Oka Y, Sugiyama H, Fujita S, Tanimoto M, Harada M, Yasukawa M. Makita M, et al. Among authors: fujita s. Clin Cancer Res. 2002 Aug;8(8):2626-31. Clin Cancer Res. 2002. PMID: 12171894

7

Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Kakimoto M, Hasegawa A, Fujita S, Yasukawa M. Kakimoto M, et al. Among authors: fujita s. J Virol. 2002 Oct;76(20):10338-45. doi: 10.1128/jvi.76.20.10338-10345.2002. J Virol. 2002. PMID: 12239310 Free PMC article.

8

Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.

Yasukawa M, Yamauchi H, Azuma T, Takada K, Ishimura M, Fujita S. Yasukawa M, et al. Among authors: fujita s. Eur J Haematol. 2002 Aug;69(2):112-4. doi: 10.1034/j.1600-0609.2002.02759.x. Eur J Haematol. 2002. PMID: 12366716

9

A novel fusion variant of the MORF and CBP genes detected in therapy-related myelodysplastic syndrome with t(10;16)(q22;p13).

Kojima K, Kaneda K, Yoshida C, Dansako H, Fujii N, Yano T, Shinagawa K, Yasukawa M, Fujita S, Tanimoto M. Kojima K, et al. Among authors: fujita s. Br J Haematol. 2003 Jan;120(2):271-3. doi: 10.1046/j.1365-2141.2003.04059.x. Br J Haematol. 2003. PMID: 12542485 Free article.

10

Non-Hodgkin's lymphoma developing in a pacemaker pocket.

Hojo N, Yakushijin Y, Narumi H, Minamoto Y, Sakai I, Takada K, Hato T, Yasukawa M, Fujita S. Hojo N, et al. Among authors: fujita s. Int J Hematol. 2003 May;77(4):387-90. doi: 10.1007/BF02982649. Int J Hematol. 2003. PMID: 12774929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,500 results

Search Page